Lv4
490 积分 2022-04-01 加入
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV‑201): a multicentre, single-arm, phase 2 trial
16小时前
已完结
Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer
1天前
已完结
Enfortumab Vedotin and Pembrolizumab in Cisplatin-Eligible Bladder Cancer
1天前
已完结
Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial
4天前
已完结
Oncological Outcomes in Bacillus Calmette-Guérin–naïve High-risk Non–muscle-invasive Bladder Cancer Patients: A Systematic Review on Current Treatment Strategies and Future Perspectives
4天前
已完结
Self-Assembling Peptide Nanotherapeutics: Precision Targeting for Acute Lung Injury and Multimodal Intervention in Chronic Pulmonary Fibrosis
18天前
已完结
Inhalable siRNA Targeting IL-11 Nanoparticles Significantly Inhibit Bleomycin-Induced Pulmonary Fibrosis
18天前
已完结
LRRK2-targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial
18天前
已完结
The DNA sequence coding for the 5′ untranslated region of herpes simplex virus type 1 ICP22 mRNA mediates a high level of gene expression
1个月前
已完结
Clinical applications of palifermin: amelioration of oral mucositis and other potential indications
1个月前
已完结
皖公网安备34019202002308
